The U.S. Supreme Court said April 14 it would temporarily keep in place status quo federal regulations regarding the use of an abortion drug, giving the court additional time to consider a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug.
A federal appeals court in a 2-1 ruling just before midnight April 12 stopped part of the recent order by a Texas judge to suspend approval of the abortion pill mifepristone but the new ruling also put restrictions on the drug’s use.
Two very different rulings on April 7 by federal judges on the abortion drug mifepristone highlight the country’s disparate views on the subject and signal that the Supreme Court will likely have to weigh in on the drugs’ future availability.
California Governor Gavin Newsom said on March 8 that the state will revoke its $54 million contract with Walgreens after the pharmacy giant stated it would not sell an abortion pill by mail in states that have outlawed its use.
